Skip to content

Beijing Biostar Pharmaceuticals Co Ltd Sustainability Reports

Beijing Biostar Pharmaceuticals Co., Ltd. is a synthetic biology-driven biopharmaceutical company that develops innovative oncology drugs. Its focus centers on the research and development of microbial metabolite-based treatments like Utidelone.

Sector: Manufacturing

Country: China

Exchange: Hong Kong Stock Exchange

FIGI: BBG01QGGQHH4

2 reports from 2024 to 2025